Navigation Links
Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
Date:4/30/2008

WALTHAM, Mass., April 30 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), today announced that it has appointed Eliot M. Lurier, CPA, as its Chief Financial Officer.

Lewis H. Bender, Chief Executive Officer of Interleukin Genetics, Inc., commented on the appointment, "Eliot is an innovative and experienced senior financial executive with an entrepreneurial spirit and a proven record of achievement in managing growth for publicly traded companies. The addition of Eliot to the senior management team provides financial management and operational skills that we need to develop and grow our business."

Mr. Lurier, age 50, has more than 25 years of financial management experience, primarily in the life sciences industry. Prior to joining Interleukin Genetics, he was Vice President, Finance and Administration and Chief Financial Officer of Nucryst Pharmaceuticals (Nasdaq: NCST, TSX: NCS), where he successfully completed a $45 million IPO within 6 months of joining the company and was responsible for SEC reporting and the implementation of Sarbanes-Oxley requirements. Previously, he served as Chief Financial Officer and Chief Operating Officer for Bridge Pharmaceuticals, Inc., where he established all policies for managing business operations.

Mr. Lurier commented, "I am very excited about the opportunity to join Interleukin Genetics. The Company is well positioned to become a leading provider of preventive consumer products and genetic tests for sale to the emerging personalized health market. I look forward to helping the Company communicate the value of such tests to the investment community."

Prior to joining Bridge Pharmaceuticals, Inc., Mr. Lurier held a number of senior-level financial positions i
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
2. Interleukin Genetics Retains Top Life Science Communications Firms
3. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
4. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
5. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
6. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
7. Interleukin Genetics Announces Management and Board Appointments
8. deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results
9. U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
10. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
11. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Nearly everyone ... serious diseases. Yet few people realize that a rich source of these cells is ... adults, and teeth that need to be pulled to make room for braces. ...
(Date:7/28/2015)... , July 28, 2015  PDL BioPharma, Inc. (PDL, ... that the Company will release its second quarter 2015 ... on Wednesday, August 5, 2015, after market close. PDL,s ... day at 4:30 p.m. Eastern Time to discuss the ... will be available via the webcast link on the ...
(Date:7/28/2015)... 21, 2015 Research ... addition of the "Analysis of the Global ... offering. Globally, flow cytometry remains a ... proliferation, cancer, and stem cells. But the market ... because of demand from underdeveloped nations to quantitate ...
(Date:7/28/2015)... Tauriga Sciences, Inc. (OTCQB:  TAUG) or ("Tauriga" ... announced that its stockholders approved an increase in the ... Company from 1,000,000,000 to 2,500,000,000 at its Special Meeting ... Law Offices of Nixon Peabody LLP in Midtown Manhattan ... 480,655,929 shares of common stock represented either by proxy ...
Breaking Biology Technology:Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Toothâ„¢ Dental Stem Cell Banking Available to their Patients 2PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3
... June 3 Reportlinker.com announces that a new market research report is available in its catalogue: ... Biomarkers - technologies, markets and companies , ... , , , ... This report follows the broad definition of a ...
... ... Researchers to Stay Informed on Current ePRO Topics , ... Pittsburgh, PA (Vocus) June 3, 2010 -- ... for global clinical research, today announced two additions to its ongoing, PROficiency™ educational program. ...
... , , ... , , ... , , , ... announces positive Phase III data from its,second pivotal study (PEARL I) for its lead product Esmya (ulipristal,acetate), ...
Cached Biology Technology:Reportlinker Adds Biomarkers - Technologies, Markets and Companies 2Reportlinker Adds Biomarkers - Technologies, Markets and Companies 3Reportlinker Adds Biomarkers - Technologies, Markets and Companies 4Reportlinker Adds Biomarkers - Technologies, Markets and Companies 5Reportlinker Adds Biomarkers - Technologies, Markets and Companies 6Reportlinker Adds Biomarkers - Technologies, Markets and Companies 7Reportlinker Adds Biomarkers - Technologies, Markets and Companies 8Reportlinker Adds Biomarkers - Technologies, Markets and Companies 9Reportlinker Adds Biomarkers - Technologies, Markets and Companies 10Reportlinker Adds Biomarkers - Technologies, Markets and Companies 11Reportlinker Adds Biomarkers - Technologies, Markets and Companies 12Reportlinker Adds Biomarkers - Technologies, Markets and Companies 13Reportlinker Adds Biomarkers - Technologies, Markets and Companies 14Reportlinker Adds Biomarkers - Technologies, Markets and Companies 15Reportlinker Adds Biomarkers - Technologies, Markets and Companies 16Reportlinker Adds Biomarkers - Technologies, Markets and Companies 17Reportlinker Adds Biomarkers - Technologies, Markets and Companies 18Reportlinker Adds Biomarkers - Technologies, Markets and Companies 19Reportlinker Adds Biomarkers - Technologies, Markets and Companies 20Reportlinker Adds Biomarkers - Technologies, Markets and Companies 21Reportlinker Adds Biomarkers - Technologies, Markets and Companies 22Reportlinker Adds Biomarkers - Technologies, Markets and Companies 23Reportlinker Adds Biomarkers - Technologies, Markets and Companies 24Reportlinker Adds Biomarkers - Technologies, Markets and Companies 25invivodata Expands Spring Educational Program 2invivodata Expands Spring Educational Program 3PregLem Announces Positive Phase III Results for Esmya(TM) 2PregLem Announces Positive Phase III Results for Esmya(TM) 3PregLem Announces Positive Phase III Results for Esmya(TM) 4
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015 ... the leading developer of human interface solutions, ... technology, the industry,s first fully hardware encapsulated ... Match-in-Sensor secure authentication technology is literally off ... storage and biometric matching within the fingerprint ...
(Date:7/8/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a ... launch of a study that aims to determine ... technology for predicting response to treatment in advanced ... the novel immunotherapy agents Yervoy® (ipilumumab), a CTLA-4 ... 50-patient study will be led by researchers at ...
(Date:7/7/2015)... , July 7, 2015  Based on its ... & Sullivan recognizes Credence ID, LLC with the ... Company of the Year Award. Credence ID has ... in its mission of offering enrollment and identification ... As Credence ID was formed by experts from ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... 2009, New York, N.Y./Los Angeles, Calif.: Stand Up ... $9.68 million to support high-risk/high-reward cancer research conducted by ... will receive a total of up to $750,000 as ... the next generation of cancer research leaders. "We ...
... of more of humanity,s food if steps are taken to ... in the December 2009 issue of BioScience. ... water and space mean that terrestrial agriculture is unlikely to ... Duarte of the University of the Balearic Islands, Spain, and ...
... with one another for space and dominance. Though the manner in ... the survival of the fittest, how stem cells duke it out ... fruit flies published in the October 2 issue of Science ... battle by literally sticking around. "Our work exemplifies how one ...
Cached Biology News:Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Stem cells battle for space 2
Neutrophil cytosol factor 2 (NCF-2) (Neutrophil NADPH oxidase factor 2) (67 kDa neutrophil oxidase factor) (p67-phox) (NOXA2). [Source:Uniprot/SWISSPROT;Acc:P19878] Antigen: Recombinant Protein E...
Rad51, N-terminal...
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... Anti-T7 [Agarose Immobilized] Goat Immunogen: ... site (MASMTGGQQMG). Antibody was isolated ... on solid support. Goat anti- human T7 ... beads using cyanogens bromide method. ...
Biology Products: